Rafarm S.A.
UkraineAll drugs from this manufacturer
-
The drug is used to reduce elevated intraocular pressure in adults with chronic open-angle glaucoma and ocular hypertension.
Dosage form: drops, ophthalmic solution
Active substance Dosage bimatoprost 0.3 mg/ml ATC: S01EE03
-
The drug is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or simply elevated ocular pressure.
Dosage form: drops, ophthalmic solution
Active substance Dosage brimonidine 2 mg/ml ATC: S01EA05
-
The drug is prescribed to reduce elevated intraocular pressure in patients with open-angle or pseudoexfoliative glaucoma if the use of beta-blockers alone is insufficient.
Dosage form: drops, ophthalmic solution
Active substance Dosage dorzolamide 20 mg/ml timolol 5 mg/ml ATC: S01ED51
-
The drug is used to reduce elevated intraocular pressure in ocular hypertension, open-angle glaucoma, or pseudoexfoliative glaucoma.
Dosage form: drops, ophthalmic solution
Active substance Dosage dorzolamide 20 mg/ml ATC: S01EC03
-
The drug is used to treat increased intraocular pressure in ocular hypertension, open-angle glaucoma, and pseudoexfoliative glaucoma.
Dosage form: drops, ophthalmic solution
Active substance Dosage dorzolamide 20 mg/ml ATC: S01EC03
-
The drug is used for the treatment of acute headache during migraine attacks (with or without aura).
Dosage form: tablets, film-coated
Active substance Dosage eletriptan 20 mg ATC: N02CC06
-
The drug is used for the treatment of acute headache during migraine attacks (with or without aura).
Dosage form: tablets, film-coated
Active substance Dosage eletriptan 40 mg ATC: N02CC06
-
The drug is used for the treatment of acute headache during migraine attacks, with or without aura.
Dosage form: tablets, film-coated
Active substance Dosage eletriptan 80 mg ATC: N02CC06
-
The drug is used for the treatment of seasonal allergic conjunctivitis.
Dosage form: drops, ophthalmic solution
Active substance Dosage olopatadine 1 mg/ml ATC: S01GX09
-
The drug is prescribed for iron deficiency if the patient cannot tolerate oral iron tablets, has gastrointestinal diseases (e.g., ulcerative colitis), or if standard tablet treatment is ineffective.
Dosage form: solution for injection or concentrate for infusion solution
Active substance Dosage iron (as iron (iii) hydroxide sucrose complex) 20 mg/ml ATC: B03AC
-
It is used to prevent bone complications (such as fractures or vertebral compression) in patients with advanced-stage tumors, as well as to treat high calcium levels (hypercalcemia) caused by malignant neoplasms.
Dosage form: concentrate for infusion solution
Active substance Dosage zoledronic acid 0.8 mg/ml ATC: M05BA08
-
The drug is used to prevent or treat nausea and vomiting caused by chemotherapy or radiotherapy, as well as for the prevention of postoperative nausea and vomiting.
Dosage form: syrup
Active substance Dosage ondansetron 0.8 mg/ml ATC: A04AA01
-
The drug is used to prevent or eliminate nausea and vomiting caused by chemotherapy, radiation therapy, or following surgical operations.
Dosage form: solution for injection
Active substance Dosage ondansetron 2 mg/ml ATC: A04AA01